Cite
Latimer J, Batty JA, Neely RD, et al. Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease. J Thromb Thrombolysis. 2016;42(3):420doi: 10.1007/s11239-016-1373-0.
Latimer, J., Batty, J. A., Neely, R. D., & Kunadian, V. (2016). Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease. Journal of thrombosis and thrombolysis, 42(3), 420. https://doi.org/10.1007/s11239-016-1373-0
Latimer, James, et al. "Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease." Journal of thrombosis and thrombolysis vol. 42,3 (2016): 420. doi: https://doi.org/10.1007/s11239-016-1373-0
Latimer J, Batty JA, Neely RD, Kunadian V. Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease. J Thromb Thrombolysis. 2016 Oct;42(3):420. doi: 10.1007/s11239-016-1373-0. PMID: 27170165; PMCID: PMC6828237.
Copy
Download .nbib